EZH2 and breast carcinoma: In breast cancer, Verlinden et al showed that E2F transcription factors can bind to the EZH2 promoter and the CHK1 promoter, suggesting that both EZH2 and CHK1 are physiological targets of the pRB-E2F pathway, which is essential for proliferation and amplification in cancer 41, 42.